John Johnson

John Johnson

Presidente presso VERASTEM, INC.

Patrimonio netto: 8 M $ in data 30/09/2026

68 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Mr. John H.
Johnson
is an Operating Partner at Healthquest Capital Management Co LLC, an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., an Independent Director at Axogen, Inc., an Independent Chairman at Verastem, Inc., an Executive Chairman at VirMedica, Inc., a Chairman at Cortendo AB, a Principal at Plum Brook Advisors LLC and an Operating Advisor at Cobepa North America, Inc. He is on the Board of Directors at Xeris Biopharma Holdings, Inc., Axogen, Inc., Cempra Pharmaceuticals, Inc. and Mirata Pharmaceuticals LLC.
Mr. Johnson was previously employed as an Executive Chairman by Applied Therapeutics, Inc., a Chief Executive Officer & Director by Reaction Biology Corp., a Non-Executive Chairman by Autolus Therapeutics Plc, a Chief Executive Officer & Director by Strongbridge Biopharma Plc, a Chairman by Corcept Therapeutics, Inc., a Lead Independent Director by Sucampo Pharmaceuticals LLC, an Independent Director by Portola Pharmaceuticals LLC, an Independent Director by Histogenics Corp., a Member-Health Section Governing Board by Biotechnology Industry Organization, a Chief Executive Officer-Emeritus by Dendreon Corp., a President, Chief Executive Officer & Director by Savient Pharmaceuticals, Inc., a Chairman by Tranzyme Pharma, Inc. (Canada), a Chairman by OCERA Therapeutics LLC, an Independent Director by Cempra, Inc., a President-Oncology Unit by Eli Lilly & Co., a Chief Executive Officer & Director by ImClone Systems, Inc., a President by Ortho Biotech Products LP, a Vice President by CNS Pharmaceuticals, Inc.,

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
04/06/2026 707.276 ( 0,39% ) 7 M $ 30/09/2026
24/06/2026 14.150 ( 0,03% ) 593 168 $ 30/09/2026
21/05/2026 52.666 ( 0,06% ) 423 961 $ 30/09/2026

Posizioni attive di John Johnson

SocietàPosizioneInizio
VERASTEM, INC. Presidente 15/12/2025
AXOGEN, INC. Direttore/Membro del Consiglio 19/07/2021
XERIS BIOPHARMA HOLDINGS, INC. Direttore/Membro del Consiglio 05/10/2021
Fondatore 01/08/2014
Presidente 09/11/2015
Direttore/Membro del Consiglio -
Consulente / Consigliere -
Investitore di Private Equity 01/01/2023
Presidente 17/03/2015
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░

Precedenti posizioni note di John Johnson

SocietàPosizioneFine
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di John Johnson

Formazione di John Johnson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

79

Relazioni di 1° grado

41

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private41

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Commercial Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Tranzyme Pharma, Inc. (Canada)

Health Technology

Health Technology

Commercial Services

Commercial Services

Finance

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Mercati
  2. Insiders
  3. John Johnson